Brief: Argenica Therapeutics Says US FDA Placed Clinical Hold On Investigational New Drug Application
10/06/2025 02:36
June 10 (Reuters) - Argenica Therapeutics Ltd AGN.AX: US FDA PLACED CLINICAL HOLD ON COMPANY'S INVESTIGATIONAL NEW DRUG APPLICATION FDA SAYS NON-CLINICAL DATA INADEQUATE FOR AIS TRIAL INITIATION EXPECTS FURTHER FDA CORRESPONDENCE WITHIN 30 DAYS Further company coverage: AGN.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argenica Therapeutics
See all newsBrief: Argenica Therapeutics Says IND Application Advanced With Successful Completion Of Assay
Brief: Argenica Therapeutics Says Dianne Angus To Step Down As Non-Executive Chair
Australia's Argenica Therapeutics jumps on meeting FDA condition
Brief: Argenica Therapeutics Seeks Trading Halt
Brief: Argenica Therapeutics Gets Non-Dilutive Funding Up To A Total Of A$1.5M